As for the clinicopathological characteristics, HR+/HER2‐ group tended to have an increasing rate of special histologic subtype (15.3%), a lower tumor histologic grade (grade 1, 33.1%), and a less incidence of nodal involvement (N0/N1mi, 96.2%). Here, ERBB2 is linked to neoplasm.